Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth vs Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index Fund-Direct Plan-Growth
Side-by-side comparison of NAV, returns, expense ratio and star rating.
TopFund Analysis
Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index Fund-Direct Plan-Growth appears stronger in terms of star rating, boasting a 5-star rating compared to Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth's 4-star rating. However, Edelweiss offers significantly higher returns over the 1-year and 3-year periods, with 13.23% and 18.85% CAGR respectively, compared to Kotak's 5.84% and 7.48%. Investors should consider the tradeoff between higher returns with Edelweiss and a lower expense ratio with Kotak, which may appeal to those prioritizing cost efficiency. Ultimately, the choice may come down to whether an investor values higher historical returns or a higher rating and lower expense ratio.
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth
Edelweiss Mutual Fund
★★★★★
Other · Index Funds
Kotak Nifty SDL Apr 2027 Top 12 Equal Weight Index Fund-Direct Plan-Growth
Kotak Mahindra Mutual Fund
★★★★★
Other · Index Funds
| Metric | Edelweiss MSCI India D... | Kotak Nifty SDL Apr 20... |
|---|---|---|
| NAV | ₹23.86 | ₹13.39 |
| Star Rating | ★★★★ | ★★★★★ |
| Expense Ratio | 0.59% | 0.2012% |
| AUM | ₹1,541 Cr | ₹6,136 Cr |
| 1M Return | -4.71% | +0.62% |
| 3M Return | -1.87% | +1.28% |
| 6M Return | +12.92% | +2.88% |
| 1Y Return | +13.23% | +5.84% |
| 3Y CAGR | +18.85% | +7.48% |
| 5Y CAGR | +13.59% | — |
| Risk Level | — | — |
| Fund Manager | Aditya Khemani | Abhishek Bisen |